Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fijnheer

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|June 1, 1997
The origin of P-selectin as a circulating plasma proteinR Fijnheer, C J Frijns, J Korteweg, et al.
Histopathology|March 26, 2003
Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationM R Canninga-van Dijk, C J Sanders, L F Verdonck, et al.
British Journal of Haematology|April 12, 2000
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemiaJ C Meijers, E J Oudijk, L O Mosnier, et al.
Transfusion|September 1, 1990
Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methodsR Fijnheer, R N Pietersz, D de Korte, et al.
Blood|June 25, 1999
von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbationJ A van Mourik, R Boertjes, I A Huisveld, et al.
Annals of the New York Academy of Sciences|December 14, 2002
Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular diseaseF-E de Leeuw, M de Kleine, C J M Frijns, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcomeC J M Frijns, R Fijnheer, A Algra, et al.
Transfusion|May 1, 1997
Improvement of platelet storage conditions by using new polyolefin containersJ de Wildt-Eggen, J G Schrijver, H J Bouter-Valk, et al.
Neurology|December 13, 2006
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathyJ M F Niermeijer, M Eurelings, H Lokhorst, et al.
British Journal of Haematology|March 1, 1997
Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantationH van Ojik, D H Biesma, R Fijnheer, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|June 1, 1997
The origin of P-selectin as a circulating plasma proteinR Fijnheer, C J Frijns, J Korteweg, et al.
Histopathology|March 26, 2003
Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationM R Canninga-van Dijk, C J Sanders, L F Verdonck, et al.
British Journal of Haematology|April 12, 2000
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemiaJ C Meijers, E J Oudijk, L O Mosnier, et al.
Transfusion|September 1, 1990
Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methodsR Fijnheer, R N Pietersz, D de Korte, et al.
Blood|June 25, 1999
von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbationJ A van Mourik, R Boertjes, I A Huisveld, et al.
Annals of the New York Academy of Sciences|December 14, 2002
Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular diseaseF-E de Leeuw, M de Kleine, C J M Frijns, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcomeC J M Frijns, R Fijnheer, A Algra, et al.
Transfusion|May 1, 1997
Improvement of platelet storage conditions by using new polyolefin containersJ de Wildt-Eggen, J G Schrijver, H J Bouter-Valk, et al.
Neurology|December 13, 2006
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathyJ M F Niermeijer, M Eurelings, H Lokhorst, et al.
British Journal of Haematology|March 1, 1997
Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantationH van Ojik, D H Biesma, R Fijnheer, et al.
Pageof 7